HUMA Humacyte shares rise nearly 7 percent after Q4 2025 earnings narrowly beat consensus analyst estimates Sabra SBRA Stock Risk Factors Evaluation Q4 2025 EPS Misses Views DHIL Diamond Hill reports Q1 2025 earnings with 26 percent year over year revenue dip shares trade flat Is Nuveen New NNY stock a reasonable investment choice